Loading
Latest filing published 24 Mar 2025 for Alzamend Neuro, Inc., €4,650.
Not enough history yet: 1 closed purchase, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
David J. Katzoff is a declared insider at 2 companies; the most frequent names are Alzamend Neuro, Inc. and TurnOnGreen, Inc. Between 14 September 2022 and 21 March 2025, the trades on record add up to 4 filings.
No open-market sale appears; the market trades are 3 purchases worth €25k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Since January 2025: 1 purchase and no sales on the market.
Half of the purchases are above €9,683 and half below. On 2 out of 3 purchases, another insider of the same company was buying within the same 30 days. Purchases made close together by different insiders form what is called a cluster.
On 24 March 2025 came the latest disclosure, an open-market purchase for €4,650 in Alzamend Neuro, Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations